20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#3902iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS
#3903NOVEL FORMULATIONS COMPRISING CANNABIS
#3904USE OF LIPOSOMAL WNT COMPOSITIONS TO ENHANCE OSSEOINTEGRATION
#3905Antimicrobial Composition
#3906FINGOLIMOD EXTENDED RELEASE INJECTABLE SUSPENSION
#3907PHARMACEUTICAL COMPOSITION COMPRISING TRANS - CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS
#3908PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS
#3909STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#3910DIHYDRATE OF BENZOTHIOPHENE COMPOUND OR OF A SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME
#3911Hydrodynamic Methods for Delivering Fluids to Kidney Tissues and Related Materials and Methods
#3912COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE
#3913USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
#3914COMPOUNDS FOR THE TREATMENT OF NEUROPATHIC PAIN
#3915STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
#3916COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
#3917COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#3918HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#3919METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#3920Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#3921Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
#3922Anti-PHF-Tau Antibodies and Uses Thereof
#3923THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED DOCETAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
#3924COMBINATION THERAPIES COMPRISING TARGETED THERAPEUTICS
#3925Compositions and methods for treating neurological disorders
#3926USE OF MESENCHYMAL STEM CELLS AND COMPOSITIONS CONTAINING THEM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING HARD-TO-HEAL BURN WOUNDS
#3927PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#3928ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
#3929PHARMACEUTICAL COMPOSITIONS COMPRISING CABOTEGRAVIR
#3930Use of senicapoc for treatment of stroke
#3931Pharmaceutical Combinations
#3932PROGESTERONE FORMULATION TO TRIGGER OVULATION AND PROVIDE LUTEAL PHASE SUPPORT
#3933METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED LYMPHOCYTES AND/OR RETROVIRAL PARTICLES
#3934METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS
#3935PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS
#3936USE OF 5-METHYLTETRAHYDROFOLATE
#3937METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY
#3938DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
#3939COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
#3940NOVEL METHODS OF GENERATING ANTIBODIES
#3941METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS
#3942LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODY
#3943Treatment of pain by administration of sustained-release liposomal anesthetic compositions
#3944COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECT
#3945COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF
#3946METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS
#3947COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING CORONAVIRUS VARIANT INFECTIONS AND METHODS OF USING THE SAME
#3948MICRO-RNA PROFILING, COMPOSITIONS, AND METHODS OF TREATING DISEASES
#3949METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#3950PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY
#3951TARGETING MICRORNA FOR CANCER TREATMENT
#3952Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
#3953IMPLANTABLE PUMP FOR DIRECT SODIUM REMOVAL THERAPY HAVING ON-BOARD ANALYTE SENSOR
#3954Methods for treating pulmonary non-tuberculous mycobacterial infections
#3955COMBINATION THERAPY OF PEPTIDOMIMETIC MACROCYCLES
#3956Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
#3957ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE
#3958SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR TREATING CANCER
#3959METHODS OF TREATING FIBROBLAST GROWTH FACTOR 19-MEDIATED CANCERS AND TUMORS
#3960Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus Therewith
#3961A METHOD OF TREATMENT IN PREDISPOSED SUBJECTS FOR LMNA-RELATED DILATED CARDIOMYOPATHY
#3962METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
#3963Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and fragile X syndrome
#3964TREATMENT OF MILD TRAUMATIC BRAIN INJURY
#3965LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION
#3966Abiotic anti-VEGF nanoparticle
#3967Compositions and Methods for Targeting Cancer Stem Cells
#3968Viscosity-reducing excipient compounds for protein formulations
#3969PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#3970THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION
#3971Pharmaceutical composition comprising a GLP-1-agonist and methionine
#3972Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#3973Coronavirus Therapeutics and Treatment Methods
#3974Hydroxypropyl beta-cyclodextrin compositions and methods
#3975EXOSOMES FOR THE TREATMENT OF INTERSTITIAL CYSTITIS
#3976METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS
#3977EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
#3978METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
#3979COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#3980Methods and compositions for CNS delivery of iduronate-2-sulfatase
#3981AMINO-PYRIMIDINE SKELETAL MUSCLE MODULATORS
#3982Aripiprazole formulations having increased injection speeds
#3983Combinations of mRNAs encoding immune modulating polypeptides and uses thereof
#3984SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOF
#3985METHODS FOR TREATING CANCER
#3986BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOF
#3987VEGFR-FC FUSION PROTEIN FORMULATIONS
#3988Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#3989METHODS OF TREATING RESPIRATORY DISORDERS
#3990Sterile aqueous choline salt compositions
#3991ADMINISTRATION OF YUNNAN BAIYAO OR XINGNAOJING IN PATIENTS WITH MODERATE-TO-SEVER TRAUMATIC BRAIN INJURY AND CRANIOTOMY
#3992Norovirus fusion proteins and VLPs comprising norovirus fusion proteins
#3993FGF analog
#3994BLOOD-BRAIN BARRIER PERMEABLE HETERODUPLEX NUCLEIC ACID
#3995ADENOSINE A2A RECEPTOR ANTAGONISTS
#3996DEPOT ADMINISTRATION OF ILOPERIDONE
#3997SEMAGLUTIDE FOR USE IN MEDICINE
#3998SYNTHESIS OF 3 -RNA OLIGONUCLEOTIDES
#3999PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE
#4000PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4001PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4002COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA
#4003INFECTIOUS DISEASE VACCINES
#4004COMPOSITION FOR TREATING SYNUCLEINOPATHIES
#4005Injectable drug delivery implant composition and method of use thereof
#4006MESOPOROUS SILICA NANOPARTICLES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#4007METHOD FOR ADMINISTRATION OF URSODEOXYCHOLIC ACID
#4008EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN
#4009PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4010NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#4011Phenylephrine hydrochloride ready-to-use solution
#4012Methods for treating neutropenia
#4013COMPOSITIONS FOR THE TREATMENT OF HYPERKERATOSIS DISORDERS
#4014Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4015METHODS FOR DELAYING ONSET OF TYPE 1 DIABETES
#4016URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#4017LONG-ACTING INJECTION DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS
#4018TREATMENT OF ACUTE AND CHRONIC KIDNEY DISEASE
#4019PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4020KRAS mutant protein inhibitors
#4021Treatment of diabetes and chronic pancreatitis using botulinum toxin
#4022Dosing regimens associated with extended release paliperidone injectable formulations
#4023GRK2 INHIBITORS AND USES THEREOF
#4024NEW COMPOSITION
#4025Methods of Treating Eye Disorders
#4026Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
#4027POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE
#4028PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#4029METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES
#4030Compositions and methods for treatment of thyroid eye disease
#4031PEPTIDES FOR REGULATING GLUCOSE
#4032ACC INHIBITOR AND USE THEREOF
#4033LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES
#4034USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONS
#4035Treatments for retinal disease
#4036Adeno-Associated Virus Vector Delivery of Microrna-29 to Treat Muscular Dystrophy
#4037NANOPARTICLE COMPOSITIONS AND METHODS OF USE
#4038Glycan-Interacting Compounds and Methods of Use
#4039Adjuvant treatment of HER2-positive breast cancer
#4040METHODS FOR TREATING PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
#4041Combinations of Vaccines and Neutralizing Antibodies for Treating Human Immunodeficiency Virus Infection in Subjects Undergoing Antiretroviral Treatment
#4042MESOPOROUS SILICA COMPOSITIONS COMPRISING INFLAMMATORY CYTOKINES FOR MODULATING IMMUNE RESPONSES
#4043UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
#4044Compositions and methods for treatment of GCase related disease states
#4045METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS
#4046NEW USE OF REGEND001 CELL AUTOLOGOUS DELIVERABLE PREPARATION IN TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
#4047METHOD OF USING ALLOGENEIC HAPLOIDENTICAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN THE TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME PATIENT
#4048Oxygen gas sustained released nano-emulsion composition and method for producing the same
#4049METHODS FOR TREATING HEPATITIS B INFECTION
#4050TREATING MITOCHONDRIAL DNA DEPLETION DISORDERS
#4051METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
#4052PEMETREXED FORMULATIONS
#4053PHOSPHOLIPID FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#4054Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer
#4055Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
#4056COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS
#4057BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#4058PARENTERAL DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS
#4059IMPROVING RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION
#4060A COMBINATION OF A BTK INHIBITOR AND ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
#4061COMPOUND FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE
#4062IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION
#4063Combination composition
#4064HIGH CONCENTRATION MEDICANT SOLUTIONS FOR TREATING NEUROLOGICAL DISORDERS
#4065Process for preparing microparticles containing glatiramer acetate
#4066OPIOID INDEPENDENT SURGICAL ANESTHETIC
#4067COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS
#4068Anti-TrkB monoclonal antibodies and methods of use
#4069Anti-CD28 Humanized Antibodies Formulated for Administration to Humans
#4070Anti-ApoE antibodies
#4071COMPOUNDS USEFUL IN HIV THERAPY
#40721-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases
#4073JNK INHIBITORS AS ANTICANCER AGENTS
#4074Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid
#4075Medication infusion components and systems
#4076DOSAGE FORM FOR EXTENDED RELEASE OF AN ANTIBODY OR LARGE PROTEIN
#4077CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE AND METHODS OF USING THE SAME
#4078CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS
#4079Heparin-Associated Polypeptides and Uses Thereof
#4080METHODS AND COMPOSITIONS FOR USE AS A PRE-TREATMENT FOR HIV THERAPIES
#4081In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
#4082BENZODIAZEPINE DERIVATIVES FOR TREATING A RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION
#4083PEMETREXED FORMULATIONS
#4084PEMETREXED FORMULATIONS
#4085Freeze dried drug nanosuspensions
#4086INJECTABLE FORMULATION OF HYDROXYCHLOROQUINE
#4087TREATMENT OF NEURODEGENERATION VIA REPROGRAMMING METABOLISM BY INHIBITING PHD
#4088Pharmaceutical Compositions, Formulations And Methods For The Treatment Of Retinoblastoma
#4089Norepinephrine compositions and methods therefor
#4090ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT
#4091STABLE PARENTERAL FORMULATIONS OF DULOXETINE
#4092COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID
#4093AAV-BASED DELIVERY OF THYMINE KINASE 2
#4094EFFECTIVE DOSAGES OF AN ADENOVIRAL-BASED BIOLOGICAL DELIVERY AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS IN HUMANS, AND COMPOSITIONS COMPRISING THE SAME
#4095METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION
#4096COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4097Broad-spectrum anti-infective peptides
#4098EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#4099COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
#4100TREATMENT OF CYR61- AND VEGF-MEDIATED CONDITIONS
#4101Process for the synthesis of substituted chloromethyl dialkylphosphates
#4102Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia
#4103ANGIOTENSIN RECEPTOR BLOCKERS FOR TREATMENT OF FIBROTIC DISEASE
#4104COMPOSITIONS AND METHODS FOR RESCUING RETINAL AND CHOROIDAL STRUCTURE AND FUNCTION
#4105TREATMENTS OF DIABETIC MACULAR EDEMA AND IMPAIRED VISUAL ACUITY
#4106CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONS
#4107COMPOSITIONS AND METHODS OF INDUCING DIFFERENTIATION OF A HAIR CELL
#4108High Concentration Bispecific Antibody Formulations
#4109CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC DEGENERATIVE DISEASE
#4110Coronavirus vaccine
#4111NEUROTOXINS FOR USE IN MINIMIZING SCARRING
#4112Means and methods for AAV gene therapy in humans
#4113PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4114Methods for treating pulmonary non-tuberculous mycobacterial infections
#4115TARGETED THERAPEUTICS
#4116Cancer Treatment Using Camptothecin Derivatives
#4117MODULAR, OXYGEN-GENERATING MICROBEAD MATERIALS FOR SUPPORTING CELL VIABILITY AND FUNCTION
#4118METHODS AND PROCESSES FOR ENHANCING THE AESTHETIC APPEARANCE OF A FACE
#4119ENGINEERED TYROSINE AMMONIA LYASE
#4120Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
#4121USE OF IL-1BETA BINDING ANTIBODIES
#4122SRPK1 INHIBITORS
#4123RADIOPHARMACEUTICAL AND METHODS
#4124Compositions of a polyorthoester and an aprotic solvent
#4125Vaccine compositions having improved stability and immunogenicity
#4126ASC SPECKS IN CANCER IMMUNOTHERAPY
#4127TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO
#4128TREATMENTS FOR EXUDATIVE MACULOPATHIES
#4129COMPOSITIONS AND METHODS FOR DIETARY MANAGEMENT OF IMMUNE HEALTH
#4130Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type
#4131METHODS FOR TREATING PAIN
#4132USE OF GHOST NANOVESICLES AS THERAPEUTICS
#4133Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4134PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4135PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4136Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4137PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4138Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4139INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE TREATMENT OF MULTIPLE SCLEROSIS
#4140System and Method of Using Hypochlorous Acid Made from Saltwater with Sodium Bicarbonate
#4141Liquid Pharmaceutical Composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine
#4142LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO TUMOR ENDOTHELIUM
#4143Treatment of submental fat
#4144MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE
#4145FULVESTRANT FORMULATIONS
#4146PROSTACYCLIN ANALOGUE FORMULATIONS
#4147ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAME
#4148TYPE V PHOSPHODIESTERASE INHIBITOR COMPOSITIONS, METHODS OF MAKING THEM AND METHODS OF USING THEM IN PREVENTING OR TREATING ELEVATED PULMONARY VASCULAR PRESSURE OR PULMONARY HEMORRHAGES
#4149USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUND FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DEVELOPMENTAL DISABILITY
#4150Pharmaceutical Combination and Use Thereof
#4151COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO AND/OR RESPIRATORY DEPRESSION
#4152Pharmaceutical composition for treating migraine
#4153D-serine inhibits neuroinflammation due to a brain injury
#4154CERAMIDE ANALOG SACLAC MODULATES SPHINGOLIPID LEVELS AND MCL-1 SPLICING TO INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA
#4155Method of Dosing a Pain Therapeutic
#4156TAP BLOCK INJECTION DEVICE
#4157Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof
#4158BIODEGRADABLE ULTRA-PH SENSITIVE POLYMERS
#4159Biopharmaceutical compositions and methods for pediatric patients
#4160METHOD FOR TREATING MUSCLE ATROPHY AND/OR OBESITY AND COMPOSITION FOR USE IN SAID METHOD
#4161COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#4162METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS
#4163PHASE-SEGREGATED VESICLES FOR SPATIALLY CONTROLLED PROTEIN-CONJUGATION AND CELL THERAPY
#4164Lipid nanoparticle compositions and methods for mRNA delivery
#4165Anhydrous sodium thiosulfate and formulations thereof
#4166CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATIONS
#4167Methods of Treating Cancer with Anti-PD-1 Antibodies
#4168APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN RESPIRATORY DISEASE
#4169TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS
#4170PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#4171COMPOSITIONS AND METHODS OF USING MULTIPOTENT STEM CELLS TO REDUCE DISEASE AND ENHANCE WELLNESS
#4172Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4173Method for treating coronavirus infections
#4174VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH AZACITIDINE
#4175INJECTABLE COMPOSITIONS OF URSODEOXYCHOLIC ACID
#4176TREATMENT OF ALCOHOLIC HEPATITIS
#4177Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof
#4178TREATING COGNITIVE DISORDERS USING TRAPIDIL
#4179METHODS OF ADMINISTERING ELAGOLIX IN ASSOCIATION WITH ARTIFICIAL REPRODUCTIVE TECHNOLOGIES
#4180HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
#4181Anti-FOLR1 Immunoconjugate Dosing Regimens
#4182Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#4183METHOD AND SYSTEM FOR THERMAL STIMULATION OF TARGETED NEURAL CIRCUITS FOR THE TREATMENT OF PARKINSON'S DISEASE
#4184Microporous annealed particle gel system
#4185GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP
#4186NICOTINAMIDE ADENINE DINUCLEOTIDE ACTIVATOR AND USE THEREOF
#4187LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES
#4188FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY
#4189STABILIZED FORMULATIONS
#4190ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
#4191Vaccines Against Coronavirus and Methods of Use
#4192Synthetic pDNA vaccines against COVID-19
#4193Cellular adjuvants for viral infection
#4194METHODS OF ADMINISTRATION OF IL-2 RECEPTOR AGONISTS
#4195METHOD OF TREATMENT OF CANCER OR TUMOUR
#4196COMPOSITIONS AND METHODS FOR ENHANCING NEURO-REPAIR
#4197HUMAN UMBILICAL CORD COMPOSITIONS AND METHODS FOR INTRA-ARTICULAR THERAPY
#4198NUCLEIC ACID COMPLEX
#4199COMBINATION TREATMENT OF SYSTEMIC FUNGAL INFECTIONS
#4200VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH A CYP3A INHIBITOR AND AZACITIDINE